Macular edema related to retinal vein occlusions
Real-life efficacy of bevacizumab
978-620-3-95212-4
6203952125
68
2021-07-21
39.90 €
eng
https://images.our-assets.com/cover/230x230/9786203952124.jpg
https://images.our-assets.com/fullcover/230x230/9786203952124.jpg
https://images.our-assets.com/cover/2000x/9786203952124.jpg
https://images.our-assets.com/fullcover/2000x/9786203952124.jpg
Retinal vein occlusion is a common and potentially serious retinal pathology. Macular edema is the main cause of blindness in retinal vein occlusions. Its diagnosis and monitoring is based on optical coherence tomography, which is a non-invasive and rapid means of exploration that allows both quantitative and qualitative analysis. Its treatment is based on intravitreal injections of anti-VEGF (Vascular Endothelial Growth Factor) such as Bevacizumab, a widely used molecule.We propose to study the efficacy of intravitreal injections of Bevacizumab in the treatment of macular edema related to retinal vein occlusions based on tomographic data.
https://www.morebooks.de/books/pt/published_by/our-knowledge-publishing/398698/products
Disciplinas clínicas
https://www.morebooks.de/store/pt/book/macular-edema-related-to-retinal-vein-occlusions/isbn/978-620-3-95212-4